Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453044
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-30
Brief Title:
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients with Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Sponsor:
Organization:
City of Hope Medical Center